Reduction of PTV margins for elective pelvic lymph nodes in online adaptive radiotherapy of prostate cancer patients

被引:2
作者
Brennsaeter, John Alfred [1 ]
Dahle, Tordis Johnsen [1 ]
Moi, Jannicke Nokling [1 ]
Svanberg, Ingvild Forsvoll [1 ]
Haaland, Gry Sandvik [1 ]
Pilskog, Sara [1 ,2 ]
机构
[1] Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway
[2] Univ Bergen, Dept Phys & Technol, Bergen, Norway
关键词
Margins; online adaptive; prostate cancer; pelvic lymph nodes; aRT; HIGH-RISK; RADIATION-THERAPY; CONSENSUS; MOTION; GUIDELINES; VOLUMES; BOOST;
D O I
10.1080/0284186X.2023.2252584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCone beam CT (CBCT) based online adaptive radiotherapy (oART) is a new development in radiotherapy. With oART, the requirements for planning target volume (PTV) margins differ from standard therapy because motion occurs during a session. In this study, we aim to evaluate a margin reduction for locally advanced prostate patients treated with oART.Material and methodsIntrafraction motion of the elective pelvic lymph nodes was evaluated by two radiation therapists (RTTs) for 150 fractions from 10 prostate patients treated with oART. PTV margins of 3, 4 and 5 mm where added to these lymph nodes for all patients. The seven first patients were treated with 5 mm PTV margin, while the last three patients were treated with 4 mm margin. After treatment, the RTTs reviewed the verification CBCTs and evaluated whether the various PTV margins would have covered the adapted clinical target volume, scoring each fraction as approved, inconclusive or rejected. Couch shifts corresponding to the rigid prostate match between the CBCTs were analyzed with respect to the RTT evaluation.ResultsThe RTTs approved a 4 mm margin in 95% of the fractions, while 2% of the fractions were rejected. For a 3 mm margin, 57% of the fractions were approved, while 5% were rejected. The scoring from the two RTTs was consistent; e.g., for 3 mm, one RTT approved 58% of the fractions, while the other approved 55%. If the couch was moved less than 2 mm in any direction, 70% of the fractions were approved for a 3 mm margin, compared to 32% for shifts greater than 2 mm.ConclusionIt is safe to reduce the PTV margin from 5 to 4 mm for the elective pelvic lymph nodes for prostate patients treated with oART. Further margin reductions can be motivated for patients presenting little intrafraction motion.
引用
收藏
页码:1208 / 1214
页数:7
相关论文
共 50 条
  • [21] Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences
    Muren, Ludvig Paul
    Wasbo, Ellen
    Helle, Svein Inge
    Hysing, Liv Bolstad
    Karlsdottir, Asa
    Odland, Odd Harald
    Valen, Harald
    Ekerold, Randj
    Johannessen, Dag Clement
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04): : 1034 - 1041
  • [22] An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients
    Trapp, Christian
    Oliinyk, Dmytro
    Rogowski, Paul
    von Bestenbostel, Rieke
    Ganswindt, Ute
    Li, Minglun
    Eze, Chukwuka
    Bartenstein, Peter
    Beyer, Leonie
    Ilhan, Harun
    Sheikh, Gabriel
    Unterrainer, Lena
    Stief, Christian
    Westhofen, Thilo
    Kunz, Wolfgang G.
    Unterrainer, Marcus
    Belka, Claus
    Schmidt-Hegemann, Nina-Sophie
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 918 - 923
  • [23] Preoperative Stating of Pelvic Lymph Nodes in Prostate Cancer Patients via Endorectal Magnetic Resonance Imaging
    Zugor, Vahudin
    Von Brandenstein, Melanie
    Akbarov, Ilgar
    Porres, Daniel
    Kuhn, Reinhard
    Labanaris, Apostolos P.
    ANTICANCER RESEARCH, 2018, 38 (03) : 1763 - 1765
  • [24] Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment
    Christiansen, Rasmus Lubeck
    Dysager, Lars
    Hansen, Christian Ronn
    Jensen, Henrik Robenhagen
    Schytte, Tine
    Nyborg, Christina Junker
    Bertelsen, Anders Smedegaard
    Agergaard, Soren Nielsen
    Mahmood, Faisal
    Hansen, Steinbjorn
    Hansen, Olfred
    Brink, Carsten
    Bernchou, Uffe
    RADIOTHERAPY AND ONCOLOGY, 2022, 167 : 165 - 171
  • [25] Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity
    Choo, Richard
    Hillman, David W.
    Daniels, Thomas
    Vargas, Carlos
    Rwigema, Jean Claude
    Corbin, Kimberly
    Keole, Sameer
    Vora, Sujay
    Merrell, Kenneth
    Stish, Bradley
    Pisansky, Thomas
    Davis, Brian
    Amundson, Adam
    Wong, William
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2021, 8 (02) : 41 - 50
  • [26] Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer
    Choo, Richard
    Hillman, David W.
    Mitchell, Cecilia
    Daniels, Thomas
    Vargas, Carlos
    Rwigema, Jean Claude
    Corbin, Kimberly
    Keole, Sameer
    Vora, Sujay
    Merrell, Kenneth
    Stish, Bradley
    Pisansky, Thomas
    Davis, Brian J.
    Amundson, Adam
    Wong, William
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (05): : 1085 - 1094
  • [27] Pelvic lymph nodes dissection for prostate cancer: Minilap with speculum vs laparoscopy
    Merlet, B.
    Ouaki, F.
    Pires, C.
    Lecoq, B.
    Irani, J.
    Dore, B.
    PROGRES EN UROLOGIE, 2010, 20 (04): : 279 - 283
  • [28] Pelvic lymph node recurrence in high-risk prostate cancer following prostate-only radiotherapy
    Hussain, Sameed
    Wajid, Muhammad Imran
    Omer, Muhammad
    Khan, Muhammad Yousuf
    Maqsood, Talha
    Zeb, Adnan
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2021, 22
  • [29] Optimal image guided radiation therapy strategy for organs at risk sparing in radiotherapy of the prostate including pelvic lymph nodes
    van Nunen, A.
    van der Toorn, P. P. G.
    Budiharto, T. C. G.
    Schuring, D.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (01) : 68 - 73
  • [30] Devising and external validation of a prognostic classification of metastatic involvement risk to pelvic lymph nodes in patients with newly diagnosed prostate cancer
    Leusik, E. A.
    Demeshko, P. D.
    Krasny, S. A.
    ONKOUROLOGIYA, 2015, 11 (04): : 59 - 64